Related Experiment Videos
Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase
M Matsuoka1, J Y Kato, R P Fisher
1Howard Hughes Medical Institute, St. Jude Children's Research Hospital, Memphis, Tennessee 38105.
Abstract:
The assembly of functional holoenzymes composed of regulatory D-type cyclins and cyclin-dependent kinases (cdks) is rate limiting for progression through the G1 phase of the mammalian somatic cell cycle. Complexes between D-type cyclins and their major catalytic subunit, cdk4, are catalytically inactive until cyclin-bound cdk4 undergoes phosphorylation on a single threonyl residue (Thr-172). This step is catalyzed by a cdk-activating kinase (CAK) functionally analogous to the enzyme which phosphorylates cdc2 and cdk2 at Thr-161/160. Here, we demonstrate that the catalytic subunit of mouse cdc2/cdk2 CAK (a 39-kDa protein designated p39MO15) can assemble with a regulatory protein present in either insect or mammalian cells to generate a CAK activity capable of phosphorylating and enzymatically activating both cdk2 and cdk4 in complexes with their respective cyclin partners. A newly identified 37-kDa cyclin-like protein (cyclin H [R. P. Fisher and D. O. Morgan, Cell 78:713-724, 1994]) can assemble with p39MO15 to activate both cyclin A-cdk2 and cyclin D-cdk4 in vitro, implying that CAK is structurally reminiscent of cyclin-cdk complexes themselves. Antisera produced to the p39MO15 subunit can completely deplete mammalian cell lysates of CAK activity for both cyclin A-cdk2 and cyclin D-cdk4, with recovery of activity in the resulting immune complexes. By using an immune complex CAK assay, CAK activity for cyclin A-cdk2 and cyclin D-cdk4 was detected both in quiescent cells and invariantly throughout the cell cycle. Therefore, although it is essential for the enzymatic activation of cyclin-cdk complexes, CAK appears to be neither rate limiting for the emergence of cells from quiescence nor subject to upstream regulatory control by stimulatory mitogens.
Insights
Cyclin-dependent kinase-activating kinase (CAK) activates cyclin-cdk complexes essential for cell cycle progression. A p39MO15 subunit, when assembled with cyclin H, phosphorylates and activates both cyclin A-cdk2 and cyclin D-cdk4.
Area of Science:
- Cell biology
- Molecular biology
- Biochemistry
Background:
- Cyclin-dependent kinases (cdks) and regulatory D-type cyclins control cell cycle progression.
- Catalytic activity of cyclin-cdk complexes requires phosphorylation by a cdk-activating kinase (CAK).
- CAK activates cdc2 and cdk2 at Thr-161/160, analogous to the activation of cdk4 at Thr-172.
Purpose of the Study:
- To investigate the composition and function of CAK.
- To determine if CAK can activate both cyclin A-cdk2 and cyclin D-cdk4 complexes.
- To assess the cell cycle regulation of CAK activity.
Main Methods:
- Demonstration of p39MO15 (catalytic subunit of mouse cdc2/cdk2 CAK) assembly with regulatory proteins.
- In vitro activation assays using cyclin A-cdk2 and cyclin D-cdk4.
- Immune complex CAK assays using antisera against p39MO15.
- Analysis of CAK activity in quiescent and cycling cells.
Main Results:
- The catalytic subunit p39MO15, when assembled with cyclin H, activates both cyclin A-cdk2 and cyclin D-cdk4.
- CAK activity is present in both quiescent and cycling cells.
- CAK activity is not rate-limiting for cell cycle entry from quiescence.
Conclusions:
- CAK is structurally similar to cyclin-cdk complexes.
- CAK is essential for cyclin-cdk complex activation but not rate-limiting for cell cycle progression.
- CAK activity is not subject to upstream regulatory control by mitogens.